Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 106.64 CHF -0.41% Market Closed
Market Cap: 204.6B CHF

Wall Street
Price Targets

NOVN Price Targets Summary
Novartis AG

Wall Street analysts forecast NOVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVN is 109.3 CHF with a low forecast of 84.84 CHF and a high forecast of 133.14 CHF.

Lowest
Price Target
84.84 CHF
20% Downside
Average
Price Target
109.3 CHF
2% Upside
Highest
Price Target
133.14 CHF
25% Upside
Novartis AG Competitors:
Price Targets
SANOFI
Sanofi India Ltd
42% Upside
AUROPHARMA
Aurobindo Pharma Ltd
14% Upside
FAE
Faes Farma SA
13% Upside
ZTS
Zoetis Inc
44% Upside
MEGA
Mega Lifesciences PCL
2% Upside
DHG
Dhg Pharmaceutical Joint-Stock Co
6% Upside
603520
Zhejiang Starry Pharmaceutical Co Ltd
48% Upside

Revenue
Forecast

Revenue Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's revenue is -1%. The projected CAGR for the next 3 years is 5%.

-1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's operating income is 3%. The projected CAGR for the next 3 years is 12%.

3%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Net Income
Forecast

Net Income Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's net income is 2%. The projected CAGR for the next 3 years is 17%.

2%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVN's stock price target?
Price Target
109.3 CHF

According to Wall Street analysts, the average 1-year price target for NOVN is 109.3 CHF with a low forecast of 84.84 CHF and a high forecast of 133.14 CHF.

What is Novartis AG's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Novartis AG's revenue is -1%. The projected CAGR for the next 3 years is 5%.

What is Novartis AG's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Novartis AG's operating income is 3%. The projected CAGR for the next 3 years is 12%.

What is Novartis AG's Net Income forecast?
Projected CAGR
17%

For the last 13 years the compound annual growth rate for Novartis AG's net income is 2%. The projected CAGR for the next 3 years is 17%.

Back to Top